Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
Full name: Merck Sharp & Dohme S.R.L. de C.V.
Previous name(s): Laboratorios Pro Salud, S. de R.L. ()
Legal Form: Limited Liability Company
Operational Status: Operational
Incorporation Date: 01-Sep-93
Pharmaceutics for human and animal health, industry chemical products, pigments.
Merck Sharp & Dohme S.A. de C.V. founded in 1932, is a company dedicated to the developing, manufacturing and marketing of medicines for human health in over 25 therapeutic areas such as: immunology, diabetes, gastroenterology, cardiovascular, neurology, osteoporosis and cancer, among others, as well as veterinary medicines and services. It also carries out research in pharmacology, epidemiology, bio-statistics, life sciences and others.More
|Company Tear Sheet|
|NAICS Industry Classification||✓|
|Share Price information||✕|
|Subsidiaries and Affiliates||✓|
|Key Financial Highlights||✕|
|Financial Performance Charts||✕|
|Latest M&A and ECM Deals||✕|
|EMIS Credit Analytics|
|EMIS Benchmark Score||✕|
- or -
EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.
If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.